118 related articles for article (PubMed ID: 18822384)
1. Tumor suppressor SMAR1 downregulates Cytokeratin 8 expression by displacing p53 from its cognate site.
Pavithra L; Singh S; Sreenath K; Chattopadhyay S
Int J Biochem Cell Biol; 2009 Apr; 41(4):862-71. PubMed ID: 18822384
[TBL] [Abstract][Full Text] [Related]
2. p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.
Singh K; Mogare D; Giridharagopalan RO; Gogiraju R; Pande G; Chattopadhyay S
PLoS One; 2007 Aug; 2(7):e660. PubMed ID: 17668048
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
[TBL] [Abstract][Full Text] [Related]
4. Chromatin remodelling protein SMAR1 inhibits p53 dependent transactivation by regulating acetyl transferase p300.
Sinha S; Malonia SK; Mittal SP; Mathai J; Pal JK; Chattopadhyay S
Int J Biochem Cell Biol; 2012 Jan; 44(1):46-52. PubMed ID: 22074660
[TBL] [Abstract][Full Text] [Related]
5. Chromatin remodeling protein SMAR1 regulates NF-κB dependent Interleukin-8 transcription in breast cancer.
Malonia SK; Yadav B; Sinha S; Lazennec G; Chattopadhyay S
Int J Biochem Cell Biol; 2014 Oct; 55():220-6. PubMed ID: 25239884
[TBL] [Abstract][Full Text] [Related]
6. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
[TBL] [Abstract][Full Text] [Related]
7. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
Mannefeld M; Klassen E; Gaubatz S
Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
[TBL] [Abstract][Full Text] [Related]
8. SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.
Pavithra L; Mukherjee S; Sreenath K; Kar S; Sakaguchi K; Roy S; Chattopadhyay S
J Mol Biol; 2009 May; 388(4):691-702. PubMed ID: 19303885
[TBL] [Abstract][Full Text] [Related]
9. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
10. Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice.
Kaul R; Mukherjee S; Ahmed F; Bhat MK; Chhipa R; Galande S; Chattopadhyay S
Int J Cancer; 2003 Feb; 103(5):606-15. PubMed ID: 12494467
[TBL] [Abstract][Full Text] [Related]
11. Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm.
Yang X; Wood PA; Oh EY; Du-Quiton J; Ansell CM; Hrushesky WJ
Breast Cancer Res Treat; 2009 Sep; 117(2):423-31. PubMed ID: 18651214
[TBL] [Abstract][Full Text] [Related]
12. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
Moh MC; Zhang T; Lee LH; Shen S
Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
[TBL] [Abstract][Full Text] [Related]
13. Role for Kruppel-like factor 4 in determining the outcome of p53 response to DNA damage.
Zhou Q; Hong Y; Zhan Q; Shen Y; Liu Z
Cancer Res; 2009 Nov; 69(21):8284-92. PubMed ID: 19826046
[TBL] [Abstract][Full Text] [Related]
14. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73.
Petitjean A; Ruptier C; Tribollet V; Hautefeuille A; Chardon F; Cavard C; Puisieux A; Hainaut P; Caron de Fromentel C
Carcinogenesis; 2008 Feb; 29(2):273-81. PubMed ID: 18048390
[TBL] [Abstract][Full Text] [Related]
15. Regulation of protein Citrullination through p53/PADI4 network in DNA damage response.
Tanikawa C; Ueda K; Nakagawa H; Yoshida N; Nakamura Y; Matsuda K
Cancer Res; 2009 Nov; 69(22):8761-9. PubMed ID: 19843866
[TBL] [Abstract][Full Text] [Related]
16. Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene.
Wei X; Xu H; Kufe D
Cancer Res; 2007 Feb; 67(4):1853-8. PubMed ID: 17308127
[TBL] [Abstract][Full Text] [Related]
17. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
18. The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures.
Guay D; Evoy AA; Paquet E; Garand C; Bachvarova M; Bachvarov D; Lebel M
Int J Biochem Cell Biol; 2008; 40(11):2492-507. PubMed ID: 18571458
[TBL] [Abstract][Full Text] [Related]
19. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
